Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island is a clinical research site located in Grand Island, Nebraska, United States 68803.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island has participated in 3 clinical trials with 3 currently active.
Therapeutic areas: Prostate Cancer, Prostatic Neoplasms, HER2 Positive Breast Cancer.
Sponsors: Merck Sharp & Dohme LLC, Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Grand Island
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island has 3 clinical trials on record, with 3 currently active. Their work covers Prostate Cancer, Prostatic Neoplasms, HER2 Positive Breast Cancer.
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.